| |
| |
|
| Insider
Information: |
Gray Mary Ann |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
254,396 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,852,456 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
254,396 |
|
|
| Total
Value |
$3,852,456 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mabvax Therapeutics Holdings Inc |
MBVX |
Director |
2005-03-16 |
5,000 |
2005-03-16 |
0 |
Premium* |
|
|
GTC Biotherapeutics Inc |
GTCB |
Director |
2007-12-17 |
11,000 |
|
0 |
Premium* |
|
|
Acadia Pharmaceuticals Inc |
ACAD |
|
2016-06-07 |
149,476 |
2013-08-26 |
0 |
Premium* |
|
|
Juniper Pharmaceuticals Inc |
JNP |
Director |
2018-08-14 |
0 |
2016-04-05 |
0 |
Premium* |
|
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2017-10-10 |
39,167 |
|
0 |
Premium* |
|
|
Senomyx Inc |
SNMX |
Director |
2018-11-02 |
0 |
2017-03-24 |
0 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2022-03-07 |
12,356 |
2019-03-04 |
0 |
Premium* |
|
|
Bioatla, Inc. |
BCAB |
Director |
2023-12-31 |
37,397 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,953 |
12,356 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2023-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,503 |
17,810 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,916 |
22,726 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2023-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,676 |
31,402 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2023-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,995 |
37,397 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2007-12-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2016-04-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
39,938 |
|
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2020-12-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,307 |
|
- |
|
33 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
